CoChat

High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist

Open access
Ma, Bingwei, Wang, Xingchun, Ren, Hui, Li, Yingying, Zhang, Haijiao, Yang, Muqing, Li, Jiyu · 2023 · BMC Cancer

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Background: The detailed molecular mechanism between type 2 diabetes mellitus (T2DM) and colorectal cancer (CRC) is still uncertain. Bone morphogenetic protein 4 (BMP4) dysregulation is implicated in T2DM and CRC, respectively. This study aims to investigate whether BMP4 can mediate the interaction of CRC with T2DM. Methods: We firstly explored the expression of BMP4 in The Cancer Genome Altas (TCGA) databases and CRC patients with or without DM from the Shanghai Tenth People’s Hospital. The diabetic model of CRC cell lines in vitro and the mice model in vivo were developed to explore the BMP4 expression during CRC with or without diabetes. Further inhibition of BMP4 to observe its effects on CRC. Also, glucagon-like peptide-1 receptor agonist (GLP-1RA) was used to verify the underlying mechanism of hypoglycemic drugs on CRC via BMP4. Results: BMP4 expression was upregulated in CRC patients, and significantly higher in CRC patients with diabetes (P < 0.05). High glucose-induced insulin resistance (IR)-CRC cells and diabetic mice with metastasis model of CRC had increased BMP4 expression, activated BMP4-Smad1/5/8 pathway, and improved proliferative and metastatic ability mediated by epithelial-mesenchymal transition (EMT). And, treated CRC cells with exogenously BMP inhibitor-Noggin or transfected with lentivirus (sh-BMP4) could block the upregulated metastatic ability of CRC cells induced by IR. Meanwhile, GLP-1R was downregulated by high glucose-induced IR while unregulated by BMP4 inhibitor noggin, and treated GLP-1RA could suppress the proliferation of CRC cells induced by IR through downregulated BMP4. Conclusions: BMP4 increased by high glucose promoted the EMT of CRC. The mechanism of the BMP4/Smad pathway was related to the susceptible metastasis of high glucose-induced IR-CRC. The commonly used hypoglycemic drug, GLP-1RA, inhibited the growth and promoted the apoptosis of CRC through the downregulation of BMP4. The result of our study suggested that BMP4 might serve as a therapeutic target in CRC patients with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-023-11077-w

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The expression of BMP4 was increased in CRC according to the data from the TCGA database (A) BMP4 expression was investigated in different types of cancer in the TCGA database (B, C) The expression of BMP4 was significantly increased in COAD(B) and READ(C) tumor samples(all P < 0.01) in the TCGA database (D, E) The expression of BMP4 was negatively associated with overall survival probability and disease free survival probability(all p < 0.05) BLCA, Bladder Urothelial Carcinoma; BRCA, Breast invasive carcinoma; CESC, Cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL, Cholangio carcinoma; COAD, Colon adenocarcinoma; ESCA, Esophageal carcinoma; GBM, Glioblastoma multiforme; HNSC, Head and Neck squamous cell carcinoma; KICH, Kidney Chromophobe; KIRC, Kidney renal clear cell carcinoma; KIRP, Kidney renal papillary cell carcinoma; LIHC, Liver hepatocellular carcinoma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; PAAD, Pancreatic adenocarcinoma; PRAD, Prostate adenocarcinoma; PCPG, Pheochromocytoma and Paraganglioma; READ, Rectum adenocarcinoma; SARC, Sarcoma; SKCM, Skin Cutaneous Melanoma; THCA, Thyroid carcinoma; THYM, Thymoma; STAD, Stomach adenocarcinoma; UCEC, Uterine Corpus Endometrial Carcinoma
Fig. 1 The expression of BMP4 was increased in CRC according to the data from the TCGA database (A) BMP4 expression was investigated in different types of cancer in the TCGA database (B, C) The expression of BMP4 was significantly increased in COAD(B) and READ(C) tumor samples(all P < 0.01) in the TCGA database (D, E) The expression of BMP4 was negatively associated with overall survival probability and disease free survival probability(all p < 0.05) BLCA, Bladder Urothelial Carcinoma; BRCA, Breast invasive carcinoma; CESC, Cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL, Cholangio carcinoma; COAD, Colon adenocarcinoma; ESCA, Esophageal carcinoma; GBM, Glioblastoma multiforme; HNSC, Head and Neck squamous cell carcinoma; KICH, Kidney Chromophobe; KIRC, Kidney renal clear cell carcinoma; KIRP, Kidney renal papillary cell carcinoma; LIHC, Liver hepatocellular carcinoma; LUAD, Lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; PAAD, Pancreatic adenocarcinoma; PRAD, Prostate adenocarcinoma; PCPG, Pheochromocytoma and Paraganglioma; READ, Rectum adenocarcinoma; SARC, Sarcoma; SKCM, Skin Cutaneous Melanoma; THCA, Thyroid carcinoma; THYM, Thymoma; STAD, Stomach adenocarcinoma; UCEC, Uterine Corpus Endometrial CarcinomaCC BY · PubMed Central
Fig. 2 BMP4 expression was significantly higher in CRC patients with DM than in CRC patients without DM. (A) The plasma level of BMP4 in CRC patients with DM (CA + DM group) was significantly higher than patients without DM (CA group), *compared to the CA group, P < 0.05 (B, C) The upregulation of the protein and RNA expression of BMP4 was confirmed by western blotting and qRT-PCR in CRC specimens from patients with or without DM, *compared to the CA group, P < 0.05 (D) Immunohistochemical localization of BMP4 in tumor samples of CRC patients with or without DM (scale bar = 50 μm)
Fig. 2 BMP4 expression was significantly higher in CRC patients with DM than in CRC patients without DM. (A) The plasma level of BMP4 in CRC patients with DM (CA + DM group) was significantly higher than patients without DM (CA group), *compared to the CA group, P < 0.05 (B, C) The upregulation of the protein and RNA expression of BMP4 was confirmed by western blotting and qRT-PCR in CRC specimens from patients with or without DM, *compared to the CA group, P < 0.05 (D) Immunohistochemical localization of BMP4 in tumor samples of CRC patients with or without DM (scale bar = 50 μm)CC BY · PubMed Central
Fig. 3 High glucose promoted the proliferation and metastasis of CRC cells (A) Glucose consumption was measured in different types of CRC cell lines by glucose assay kit, *P < 0.05, ***P < 0.001 (B) The result of glucose consumption was rectified by cell viability measured by CCK-8 kit (OD 450), *P < 0.05, ***P < 0.001 (C) Protein of BMP4 expression examined by western blotting in different types of CRC cell lines (D, E) Treated with high glucose(50mM) 48 h could upregulate the expression of BMP4 measured by western blotting(D) and qRT-PCR(E), *P < 0.05 (F) Cell viability of SW1116 and MC38 cultivated by high glucose(50mM) and Noggin(200nM) for 48 h assessed by CCK-8kit, *P < 0.05, ***P < 0.001 (G) Transwell assays were performed to examine the potential migration of SW1116 and MC38 cells treated with or without high glucose(50mM) and Noggin(200nM).
Fig. 3 High glucose promoted the proliferation and metastasis of CRC cells (A) Glucose consumption was measured in different types of CRC cell lines by glucose assay kit, *P < 0.05, ***P < 0.001 (B) The result of glucose consumption was rectified by cell viability measured by CCK-8 kit (OD 450), *P < 0.05, ***P < 0.001 (C) Protein of BMP4 expression examined by western blotting in different types of CRC cell lines (D, E) Treated with high glucose(50mM) 48 h could upregulate the expression of BMP4 measured by western blotting(D) and qRT-PCR(E), *P < 0.05 (F) Cell viability of SW1116 and MC38 cultivated by high glucose(50mM) and Noggin(200nM) for 48 h assessed by CCK-8kit, *P < 0.05, ***P < 0.001 (G) Transwell assays were performed to examine the potential migration of SW1116 and MC38 cells treated with or without high glucose(50mM) and Noggin(200nM).CC BY · PubMed Central
Fig. 4 High glucose promoted the EMT of SW1116 and MC38 cells through the BMP4-Smad pathway (A) Western blotting analysis of the expression of EMT markers in SW1116 and MC38 cells cultivated with or without high glucose(50mM) and Noggin(200nM). (B) High glucose activated the SMAD1/5/8 and this effect could be blocked by Noggin proved by western blot analysis (C) Western blotting analysis of the efficiency of sh-BMP4 and vector transfection in SW1116 cells (D) Western blotting analysis of the expression of BMP4, EMT markers and pSMAD1/5/8 in SW1116 transfected with sh-BMP4-2 treated with or without high glucose(50mM) for 24 h
Fig. 4 High glucose promoted the EMT of SW1116 and MC38 cells through the BMP4-Smad pathway (A) Western blotting analysis of the expression of EMT markers in SW1116 and MC38 cells cultivated with or without high glucose(50mM) and Noggin(200nM). (B) High glucose activated the SMAD1/5/8 and this effect could be blocked by Noggin proved by western blot analysis (C) Western blotting analysis of the efficiency of sh-BMP4 and vector transfection in SW1116 cells (D) Western blotting analysis of the expression of BMP4, EMT markers and pSMAD1/5/8 in SW1116 transfected with sh-BMP4-2 treated with or without high glucose(50mM) for 24 hCC BY · PubMed Central
Fig. 5 GLP-1RA diminished the proliferation of CRC. (A) The expression of GLP-1R was downregulated by high glucose presented by western blot (B) Western blotting analysis of the expression of BMP4 in SW1116 and MC38 treated with GLP-1RA, liraglutide, with different concentrations (0, 10, 20, 50, 100nM) for 48 h (C) The dead cells of SW1116 and MC38 intervened with GLP-1RA for 48 h were detected by Calcein‑AM/PI double staining (magnification, x100) (D, E) Cell viability of SW1116 and MC38 cells treated with GLP-1RA for 48 h were measured by CCK-8 kit, *P < 0.05, ***P < 0.001
Fig. 5 GLP-1RA diminished the proliferation of CRC. (A) The expression of GLP-1R was downregulated by high glucose presented by western blot (B) Western blotting analysis of the expression of BMP4 in SW1116 and MC38 treated with GLP-1RA, liraglutide, with different concentrations (0, 10, 20, 50, 100nM) for 48 h (C) The dead cells of SW1116 and MC38 intervened with GLP-1RA for 48 h were detected by Calcein‑AM/PI double staining (magnification, x100) (D, E) Cell viability of SW1116 and MC38 cells treated with GLP-1RA for 48 h were measured by CCK-8 kit, *P < 0.05, ***P < 0.001CC BY · PubMed Central
Fig. 6 GLP-1RA promoted the apoptosis of CRC cells mediated by the dimmish of BMP4. (A) GLP-1RA promotes the apoptosis of SW1116 examined by flow cytometric analysis (B) Cell viability of SW1116 and MC38 cell lines cultivated by GLP-1RA and recombinant BMP4 for 48 h assessed by CCK-8kit (C) Western blot analysis of the expression of BCL-2, Caspase-3, and cleave-Caspase-3 in SW1116 and MC38 cell lines treated with GLP-1RA and recombinant BMP4.
Fig. 6 GLP-1RA promoted the apoptosis of CRC cells mediated by the dimmish of BMP4. (A) GLP-1RA promotes the apoptosis of SW1116 examined by flow cytometric analysis (B) Cell viability of SW1116 and MC38 cell lines cultivated by GLP-1RA and recombinant BMP4 for 48 h assessed by CCK-8kit (C) Western blot analysis of the expression of BCL-2, Caspase-3, and cleave-Caspase-3 in SW1116 and MC38 cell lines treated with GLP-1RA and recombinant BMP4.CC BY · PubMed Central
Fig. 7 High glucose promoted the metastasis of CRC validated in vivo studies (A) Protocol for high-fat diet (HFD) and STZ-induced diabetes mouse models and liver metastasis model (B) Representative image of the liver of mice with diabetes (DM + CA group) and without diabetes (CA group) (C) BMP4 and E-cadherin, N-cadherin, Vimentin protein levels in formalin-fixed, paraffin-embedded tumors as detected by IHC.
Fig. 7 High glucose promoted the metastasis of CRC validated in vivo studies (A) Protocol for high-fat diet (HFD) and STZ-induced diabetes mouse models and liver metastasis model (B) Representative image of the liver of mice with diabetes (DM + CA group) and without diabetes (CA group) (C) BMP4 and E-cadherin, N-cadherin, Vimentin protein levels in formalin-fixed, paraffin-embedded tumors as detected by IHC.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. 2. Classification and diagnosis of diabetes. Diabetes Care. 2019;42:13–S28.

Cited by

See all 41

Metadata

Authors
Ma, B., Wang, X., Ren, H., Li, Y., Zhang, H., Yang, M., & Li, J.
Affiliations
  • Tongji University (CN)
  • East China University of Science and Technology (CN)
  • Fudan University (CN)
Corresponding author
Li, Jiyu
Venue
BMC Cancer
Published
2023-06-27
Volume
23
Issue
1
Pages
594-594
ISSN
1471-2407 (ISSN-L)
OpenAlex
W4382241625
Cited by
36
References
62
Citations by year
2026: 12 · 2025: 15 · 2024: 9
FWCI
3.20
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (80272647)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
colorectal cancer, type 2 diabetes, high glucose, BMP4 signaling, insulin resistance, epithelial-mesenchymal transition, metastasis, GLP-1 receptor agonists, noggin, antidiabetic drugs, therapeutic target
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Glucose, Hypoglycemic Agents, Colorectal Neoplasms, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist. https://app.cochat.ai/papers/10.1186/s12885-023-11077-w
The paper
Ma, B., Wang, X., Ren, H., Li, Y., Zhang, H., Yang, M., & Li, J. (2023). High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist. BMC Cancer. https://doi.org/10.1186/s12885-023-11077-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.